Sequencing Systems Product Manager
Oxford, UK (Oxford Science Park)
About Oxford Nanopore Technologies
Oxford Nanopore Technologies is headquartered at the Oxford Science Park, with a global presence across the US, APAC, and Europe.
Our nanopore sequencing platform is unique in offering real-time analysis, enabling rapid insights across fully scalable formats, from portable devices to population-scale systems. Our technology can analyse native DNA and RNA and sequence fragments of any length, delivering short to ultra-long reads. Our mission is simple but ambitious: to enable the analysis of any living thing, by anyone, anywhere.
The Role
We are looking for a Sequencing Systems Product Manager to join our team, supporting our low throughput sequencing systems portfolio.
In this role, you’ll work cross-functionally with R&D, marketing, commercial, operations, and regulatory teams to ensure the ongoing success, evolution, and growth of our low throughput sequencing products.
Reporting to the Director of Product Management, this position is ideal for someone with experience in product management or product marketing within Next Generation Sequencing (NGS) or life sciences
Key Responsibilities
What We’re Looking For
Why Join Us?
At Oxford Nanopore, you’ll be part of a team pushing the boundaries of what’s possible in genomics—working on technology that is transforming research, healthcare, and beyond.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability, or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-LH1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
